All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
Does 10-day decitabine improve post-transplant outcomes in older patients compared with 3+7 chemo?
Ossenkoppele begins by introducing the study presented at the congress, outlining the study design and trial results. He then highlights the overall...
The QuANTUM-First trial
The AML Hub was pleased to speak with Hee-Je Kim, The Catholic University of Korea, Seoul, KR, during the EHA 2022 Congress. Kim discussed the initial findings from the QuANTUM-First trial.
Your opinion matters
Are you a healthcare professional? What is your speciality?
Please select or type your speciality
By sharing this information, you can help ensure we continue to develop content that is of most relevance for our audience.
Thank you for submitting.